Female-founded private equity firm PEAL Capital Group has acquired a UK cosmetic training provider, Derma Med Ltd
PEAL, the private equity firm, has acquired a majority shareholding in Derma Medical for an undisclosed sum. Derma Medical, the multinational training provider at the forefront of non-surgical aesthetic treatments equips medical professionals with recognised qualifications in non-invasive injectable cosmetic procedures.
Karen O’Mahony, Managing Partner, PEAL and Tara Mandal, Partner & COO, PEAL, said that, “PEAL Capital Group’s philosophy is to acquire controlling stakes in companies with established business models, well-developed products and services and with corporate cultures that hold diversity and inclusion at their very core.”
Derma Medical has UK-wide training covering London, Birmingham, Manchester, and Edinburgh, as well as international training academies in Sydney, Brisbane, Melbourne, and Perth (Australia), Stockholm (Sweden) and Dubai (UAE), which attract delegates from around the world.
According to 2021 study by Fortune, the global facial injectables market is projected to grow from $4.77 billion in 2021 to $9.07 billion in 2028 at a CAGR of 9.6% in the forecast period, 2021-2028. Derma Medical is a leading provider of training in this field, offering medical professionals and those registered with professional statutory and regulatory bodies (PSRBs), such as the General Medical Council (GMC), Nursing and Midwifery Council (NMC), General Dental Council (GDC) and General Pharmaceutical Council (GPhC) with recognised qualifications.
PEAL Capital Group were supported in their transaction by PwC, Silicon Valley Bank, Rosetta Tax, Locke Lord, McCann FitzGerald, Waystone, SEI, Ince, Kroll & RWT Growth (who ably represented the vendors on this deal).
Karen O’Mahony added, “PEAL invests in high-quality companies with diverse management teams, and this is perfectly exemplified in Derma Medical. Every PEAL deal begins with a 100-day plan and I am pleased to report that the progress of this plan has already exceeded our expectations.”